Cytophenix
Perth
About Cytophenix
Cytophenix is developing rapid antimicrobial susceptibility tests to identify the most effective antibiotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2025)
- Website: cytophenix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cytophenix-109817 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.